Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-d-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals
- 1 January 1991
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 12 (1) , 53-59
- https://doi.org/10.1016/0168-8227(91)90130-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- N-(Cyclohexylcarbonyl)-D-phenylalanines and related compounds. A new class of oral hypoglycemic agents. 2Journal of Medicinal Chemistry, 1989
- Analysis of Enantiomers of a New Antidiabetic Agent in Plasma by High-Performance Liquid ChromatographyJournal of Liquid Chromatography, 1989
- High Performance Liquid Chromatographic Method for Quantitation of a New Antidiabetic Agent in PlasmaJournal of Liquid Chromatography, 1988
- Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.Journal of Clinical Investigation, 1987
- Islet secretion in a new experimental model for non-insulin-dependent diabetesDiabetes, 1981
- Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemiaDiabetes, 1981
- Effect of Control of Blood Glucose on Urinary Excretion of Albumin and β2Microglobulin in Insulin-Dependent DiabetesNew England Journal of Medicine, 1979
- Clinical Pharmacology of Oral Antidiabetic AgentsNew England Journal of Medicine, 1977
- Effect of multiple daily insulin injections on the course of diabetic retinopathyDiabetes, 1976
- Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*Journal of Clinical Investigation, 1967